Kalin, S. N. Et Al. 2022. Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells. CHEMICO-BIOLOGICAL INTERACTIONS , vol.361 .

Kalin, S. N., ALTAY, A., & BUDAK, H., (2022). Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells. CHEMICO-BIOLOGICAL INTERACTIONS , vol.361.

Kalin, Seyda, AHMET ALTAY, And Harun BUDAK. "Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells," CHEMICO-BIOLOGICAL INTERACTIONS , vol.361, 2022

Kalin, Seyda N. Et Al. "Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells." CHEMICO-BIOLOGICAL INTERACTIONS , vol.361, 2022

Kalin, S. N. ALTAY, A. And BUDAK, H. (2022) . "Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells." CHEMICO-BIOLOGICAL INTERACTIONS , vol.361.

@article{article, author={Seyda Nur Kalin Et Al. }, title={Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells}, journal={CHEMICO-BIOLOGICAL INTERACTIONS}, year=2022}